Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

57669 Press Releases
DateTitleCompany
19 Sep 11 Inhibitex Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients Inhibitex Inc.,
Published by
Business Wire
19 Sep 11 NanoViricides Announces Acquisition of New Space for Future Pilot cGMP Production NanoViricides Inc.,
Published by
Business Wire
19 Sep 11 Spectrum Pharmaceuticals Announces Impressive Responses in Difficult to Treat Carcinomas with SPI-1620 in a Phase I Study Spectrum Pharmaceuticals Inc.,
Published by
Business Wire
19 Sep 11 Opexa’s CEO Invited to Present at Two Cell Therapy Forums in Asia During September, 2011 Opexa Therapeutics Inc.,
Published by
Business Wire
19 Sep 11 Abiomed Announces First Patient Enrolled In MINI-AMI Study Abiomed Inc.,
Published by
Business Wire
19 Sep 11 Merck’s ISENTRESS® (raltegravir) in Combination Therapy Demonstrated Efficacy and Tolerability in an Observational Trial in a Diverse Population of Adults with HIV-1 Regardless of Gender or Race Merck,
Published by
Business Wire
19 Sep 11 Research Profiles Industry's Post-marketing Safety Conduct and Outsourcing Industry Standard Research,
Published by
Business Wire
19 Sep 11 Unigene’s Industry Leading, Proprietary Oral Delivery and Recombinant Manufacturing Technology Platforms are Further Validated with Positive Phase 3 Safety and Efficacy Data for OSTORA(TM) Unigene Laboratories Inc.,
Published by
Business Wire
19 Sep 11 Pacific Biosciences Partners With Cycle Computing to Bring SMRT DNA Analysis to the Cloud Pacific Biosciences of California Inc.,
Published by
Business Wire
19 Sep 11 Biovest and NHRC to Continue Collaboration with Shared Resources to Extend the Potential of Hollow Fiber Bioreactor Technology for Pandemic Influenza Virus Biovest International Inc.,
Published by
Business Wire
19 Sep 11 IntegraGen Announces Results from New Test Designed to Aid in the Earlier Identification of Children at Higher Risk of Autism IntegraGen,
Published by
Business Wire
19 Sep 11 New Survey: Beneficiaries, Boomers Remain Confused by Medicare UnitedHealthcare,
Published by
Business Wire
19 Sep 11 Research and Markets: Jordan Pharmaceuticals and Healthcare Report Q4 2011 - The US$400mn Grant Saudi Arabia Offered Jordan in Early June Suggests That Riyadh Will Attempt To Bring Amman Closer To Its Political Orbit Research and Markets,
Published by
Business Wire
19 Sep 11 NovaDigm Therapeutics Presents Positive Phase 1 Safety and Immunogenicity Data for NDV-3 Vaccine NovaDigm Therapeutics,
Published by
Business Wire
19 Sep 11 Hundreds of Open Services Now Being Planned for Worldwide Candle Lighting December 11 to Remember Children ERELEASES,
Published by
PR Newswire
19 Sep 11 The American Fertility Association Adds Five New Board Members ERELEASES,
Published by
PR Newswire
19 Sep 11 Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia Spinifex Pharmaceuticals
19 Sep 11 KYTHERA Biopharmaceuticals Announces $37.4M Financing KYTHERA Biopharmaceuticals Inc.,
Published by
Business Wire
19 Sep 11 Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference Human Genome Sciences Inc.,
Published by
Business Wire
19 Sep 11 InVivo Therapeutics Co-Founder Dr. Robert S. Langer Awarded the Warren Alpert Foundation Prize InVivo Therapeutics,
Published by
Business Wire
19 Sep 11 Research and Markets: Israel Pharmaceuticals and Healthcare Report Q4 2011 - Israel Now Reinstated on the Pharmaceutical Research and Manufacturers of America Special 301 Submission's Priority Watch List For 2011 Research and Markets,
Published by
Business Wire
19 Sep 11 IDT Expands its Tech Vault to Include Webinars Integrated DNA Technologies
19 Sep 11 Astech Projects will Exhibit at PPMA 2011 Astech Projects
19 Sep 11 Meda Acquires Rights to Nalox in Europe MEDA,
Published by
Business Wire
19 Sep 11 Selcia and NeuroVive to Develop New Mitochondrial Medicines for Chronic and Acute Diseases Selcia and NeuroVive,
Published by
Business Wire
19 Sep 11 Alkermes plc Launches Corporate Operations in Ireland Alkermes plc,
Published by
Business Wire
19 Sep 11 Techulon Teams with BioConcept for European Distribution Techulon Inc.,
Published by
Business Wire
18 Sep 11 Mentorship programmes needed to encourage national nursing workforce in the UAE Informa Exhibitions
18 Sep 11 BMS-790052 Plus Peginterferon Alfa and Ribavirin Demonstrated up to 83% Sustained Virologic Response 24 Weeks Post-Treatment (SVR24) in Phase II Study of Genotype 1 Hepatitis C Patients Bristol-Myers Squibb Company,
Published by
Business Wire
18 Sep 11 BioCryst To Present New Peramivir Data at the 51st Annual ICAAC Meeting BioCryst Pharmaceuticals,
Published by
Business Wire
Advertising